Colorectal Cancer Clinical Trials in Tennessee

Showing 181-184 of 184 trials

Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer

NCT00193167

This non-randomized phase II study is designed to assess the response rate and toxicity of weekly topotecan as second-line treatment in patients with relapsed or refractory metastatic colorectal cancer.

Colon Cancer

SCRI Development Innovations, LLC40 participantsStarted Jan 2004

Nashville, Tennessee, United States

COMPLETED174 miles

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

NCT00410579

RATIONALE: Learning about quality of life, symptoms, and health behaviors in colorectal cancer survivors may help to determine the long-term effects of colon and rectal cancer treatments and may help to improve the quality of life for future cancer survivors. PURPOSE: This clinical trial is looking at patient-reported outcomes in long-term survivors of colon and rectal cancers.

Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more

NSABP Foundation Inc744 participantsStarted Nov 2006

Aurora, Colorado, United States • Boulder, Colorado, United States • Colorado Springs, Colorado, United States +197 more locations

Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Colorectal Cancer Trials in Other Cities

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Other Conditions in Tennessee